The role of GLP-1s in type 2 diabetes-related kidney disease

Prof Vlado Perkovic

Speaker

Nephrologist; Provost, UNSW Sydney

Claim CPD for this activity

Educational Activities (EA)

0.5 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0.5 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

0 hours

These are activities that use your work data to ensure quality results.

EA

0.5 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP

0.5 hours

These are activities that require reflection on feedback about your work.

MO

0 hours

These are activities that use your work data to ensure quality results.

Description

In this presentation, Prof Vlado Perkovic, Nephrologist, describes the evolution to four-pillar therapy in the management of diabetic kidney disease. He also outlines the recent clinical evidence underpinning semaglutide 1.0mg’s new indication for chronic kidney disease in type 2 diabetes, and why this is an important development for GPs.

Expert speakers:

  • Prof Vlado Perkovic | Nephrologist

 

Recent videos

Share this

Date published: 15 September 2025

You have completed the Educational Activities (EA) component of this activity.

Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.

You will be taken to explore further CPD learning available to you.